journals.sagepub.com
Alectinib and gastrointestinal perforation in ALK-rearranged non-small cell lung cancer: A case series - Margherita Piccinelli, Raffaele Squitieri, Rebecca Romanò, Silvia Marchesi, Giulia Montelatici, Camilla Damonte, Marta Brambilla, Teresa Beninato, Laura Mazzeo, Giulia Corrao, Marco Meazza Prina, Arsela Prelaj, Claudia Proto, Margherita Galassi, Filippo Guglielmo Maria De Braud, Giuseppe Lo Russo, Mario Occhipinti, Paolo Ambrosini, 2026
Background: Alectinib, a second-generation ALK inhibitor, is used in first-line and adjuvant treatment for ALK-rearranged NSCLC, and has proven to be both effec...